BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Keil TW, Merkel OM. Dry powder inhalation of siRNA. Ther Deliv 2019;10:265-7. [PMID: 31094296 DOI: 10.4155/tde-2019-0018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Keil TWM, Baldassi D, Merkel OM. T-cell targeted pulmonary siRNA delivery for the treatment of asthma. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2020;12:e1634. [PMID: 32267622 DOI: 10.1002/wnan.1634] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Zhang Y, Almazi JG, Ong HX, Johansen MD, Ledger S, Traini D, Hansbro PM, Kelleher AD, Ahlenstiel CL. Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract. Int J Mol Sci 2022;23:2408. [PMID: 35269550 DOI: 10.3390/ijms23052408] [Reference Citation Analysis]
3 Mehta PP. Dry powder inhalers: upcoming platform technologies for formulation development. Therapeutic Delivery 2019;10:551-4. [DOI: 10.4155/tde-2019-0062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lechanteur A, Plougonven E, Orozco L, Lumay G, Vandewalle N, Léonard A, Evrard B. Engineered-inhaled particles: Influence of carbohydrates excipients nature on powder properties and behavior. Int J Pharm 2021;:121319. [PMID: 34875354 DOI: 10.1016/j.ijpharm.2021.121319] [Reference Citation Analysis]
5 Uludağ H, Parent K, Aliabadi HM, Haddadi A. Prospects for RNAi Therapy of COVID-19. Front Bioeng Biotechnol 2020;8:916. [PMID: 32850752 DOI: 10.3389/fbioe.2020.00916] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
6 Mehta A, Michler T, Merkel OM. siRNA Therapeutics against Respiratory Viral Infections-What Have We Learned for Potential COVID-19 Therapies? Adv Healthc Mater 2021;10:e2001650. [PMID: 33506607 DOI: 10.1002/adhm.202001650] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]